Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Thrombosis Risk in Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A in FinnGen and the UK Biobank.

Ryu, Justine; Rämö, Joel T; Jurgens, Sean Joseph; Niiranen, Teemu; Sanna-Cherchi, Simone; Bauer, Kenneth A; Haj, Amelia; Choi, Seung Hoan; Palotie, Aarno; Daly, Mark; Ellinor, Patrick T; Bendapudi, Pavan K.

Blood ; 2024 03 18.

Artigo em Inglês | MEDLINE | ID: mdl-38498041

2.

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Khorana, Alok A; Soff, Gerald A; Kakkar, Ajay K; Vadhan-Raj, Saroj; Riess, Hanno; Wun, Ted; Streiff, Michael B; Garcia, David A; Liebman, Howard A; Belani, Chandra P; O'Reilly, Eileen M; Patel, Jai N; Yimer, Habte A; Wildgoose, Peter; Burton, Paul; Vijapurkar, Ujjwala; Kaul, Simrati; Eikelboom, John; McBane, Robert; Bauer, Kenneth A; Kuderer, Nicole M; Lyman, Gary H.

N Engl J Med ; 380(8): 720-728, 2019 02 21.

Artigo em Inglês | MEDLINE | ID: mdl-30786186

3.

Managing thromboembolic risk in patients with hereditary and acquired thrombophilias.

Moran, Jason; Bauer, Kenneth A.

Blood ; 135(5): 344-350, 2020 01 30.

Artigo em Inglês | MEDLINE | ID: mdl-31917425

4.

Postdischarge thrombosis and hemorrhage in patients with COVID-19.

Patell, Rushad; Bogue, Thomas; Koshy, Anita; Bindal, Poorva; Merrill, Mwanasha; Aird, William C; Bauer, Kenneth A; Zwicker, Jeffrey I.

Blood ; 136(11): 1342-1346, 2020 09 10.

Artigo em Inglês | MEDLINE | ID: mdl-32766883

5.

Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.

Al-Samkari, Hanny; Gupta, Shruti; Leaf, Rebecca Karp; Wang, Wei; Rosovsky, Rachel P; Brenner, Samantha K; Hayek, Salim S; Berlin, Hanna; Kapoor, Rajat; Shaefi, Shahzad; Melamed, Michal L; Sutherland, Anne; Radbel, Jared; Green, Adam; Garibaldi, Brian T; Srivastava, Anand; Leonberg-Yoo, Amanda; Shehata, Alexandre M; Flythe, Jennifer E; Rashidi, Arash; Goyal, Nitender; Chan, Lili; Mathews, Kusum S; Hedayati, S Susan; Dy, Rajany; Toth-Manikowski, Stephanie M; Zhang, Jingjing; Mallappallil, Mary; Redfern, Roberta E; Bansal, Amar D; Short, Samuel A P; Vangel, Mark G; Admon, Andrew J; Semler, Matthew W; Bauer, Kenneth A; Hernán, Miguel A; Leaf, David E.

Ann Intern Med ; 174(5): 622-632, 2021 05.

Artigo em Inglês | MEDLINE | ID: mdl-33493012

6.

Should You Treat This Acutely Ill Medical Inpatient With Venous Thromboembolism Chemoprophylaxis?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Kanjee, Zahir; Bauer, Kenneth A; Breu, Anthony C; Burns, Risa.

Ann Intern Med ; 172(7): 484-491, 2020 04 07.

Artigo em Inglês | MEDLINE | ID: mdl-32252085

7.

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.

Kearon, Clive; Parpia, Sameer; Spencer, Frederick A; Baglin, Trevor; Stevens, Scott M; Bauer, Kenneth A; Lentz, Steven R; Kessler, Craig M; Douketis, James D; Moll, Stephan; Kaatz, Scott; Schulman, Sam; Connors, Jean M; Ginsberg, Jeffrey S; Spadafora, Luciana; Bhagirath, Vinai; Liaw, Patricia C; Weitz, Jeffrey I; Julian, Jim A.

Blood ; 131(19): 2151-2160, 2018 05 10.

Artigo em Inglês | MEDLINE | ID: mdl-29490924

8.

A Balancing Act.

Yang, Shu; Bauer, Kenneth A; Singleton, Jennifer M; Papavassiliou, Efstathios; Kramer, Daniel B.

Circulation ; 141(13): 1103-1106, 2020 03 31.

Artigo em Inglês | MEDLINE | ID: mdl-32223675

9.

Issues in the Diagnosis and Management of Hereditary Antithrombin Deficiency.

Bauer, Kenneth A; Nguyen-Cao, Tam M; Spears, Jeffrey B.

Ann Pharmacother ; 50(9): 758-67, 2016 09.

Artigo em Inglês | MEDLINE | ID: mdl-27281301

10.

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.

Stevens, Scott M; Woller, Scott C; Bauer, Kenneth A; Kasthuri, Raj; Cushman, Mary; Streiff, Michael; Lim, Wendy; Douketis, James D.

J Thromb Thrombolysis ; 41(1): 154-64, 2016 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-26780744

11.

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.

Kearon, Clive; Spencer, Frederick A; O'Keeffe, Denis; Parpia, Sameer; Schulman, Sam; Baglin, Trevor; Stevens, Scott M; Kaatz, Scott; Bauer, Kenneth A; Douketis, James D; Lentz, Steven R; Kessler, Craig M; Moll, Stephan; Connors, Jean M; Ginsberg, Jeffrey S; Spadafora, Luciana; Julian, Jim A.

Ann Intern Med ; 162(1): 27-34, 2015 Jan 06.

Artigo em Inglês | MEDLINE | ID: mdl-25560712

12.

Heparin induced thrombocytopenia antibodies in Covid-19.

Patell, Rushad; Khan, Adeel M; Bogue, Thomas; Merrill, Mwanasha; Koshy, Anita; Bindal, Poorva; Joyce, Robin; Aird, William C; Neuberg, Donna; Bauer, Kenneth A; Zwicker, Jeffrey I.

Am J Hematol ; 95(10): E295-E296, 2020 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-32658337

13.

How Effective and Safe Is Factor XI Inhibition in Preventing Venous Thrombosis?

Bauer, Kenneth A.

JAMA ; 323(2): 121-122, 2020 01 14.

Artigo em Inglês | MEDLINE | ID: mdl-31935013

14.

The challenge of hospital-related thrombosis.

Bauer, Kenneth A.

Blood ; 130(2): 97-98, 2017 07 13.

Artigo em Inglês | MEDLINE | ID: mdl-28705852

15.

The thrombogenicity of C1 esterase inhibitor (human): review of the evidence.

Crowther, Mark; Bauer, Kenneth A; Kaplan, Allen P.

Allergy Asthma Proc ; 35(6): 444-53, 2014.

Artigo em Inglês | MEDLINE | ID: mdl-25584911

16.

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).

Zwicker, Jeffrey I; Liebman, Howard A; Bauer, Kenneth A; Caughey, Thomas; Campigotto, Federico; Rosovsky, Rachel; Mantha, Simon; Kessler, Craig M; Eneman, Jonathan; Raghavan, Vidya; Lenz, Heinz-Joseph; Bullock, Andrea; Buchbinder, Elizabeth; Neuberg, Donna; Furie, Bruce.

Br J Haematol ; 160(4): 530-7, 2013 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-23240761

17.

Targeted Anti-Anticoagulants.

Bauer, Kenneth A.

N Engl J Med ; 373(6): 569-71, 2015 Aug 06.

Artigo em Inglês | MEDLINE | ID: mdl-26095632

18.

The dos, don'ts, and nuances of thrombophilia testing.

Chiasakul, Thita; Bauer, Kenneth A.

Hematology Am Soc Hematol Educ Program ; 2023(1): 593-599, 2023 Dec 08.

Artigo em Inglês | MEDLINE | ID: mdl-38066917

19.

Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa.

Ryu, Justine H; Bauer, Kenneth A; Schulman, Sol.

J Thromb Haemost ; 21(12): 3508-3510, 2023 12.

Artigo em Inglês | MEDLINE | ID: mdl-37734716

20.

Reversal of antithrombotic agents.

Bauer, Kenneth A.

Am J Hematol ; 87 Suppl 1: S119-26, 2012 May.

Artigo em Inglês | MEDLINE | ID: mdl-22460529

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Thrombosis Risk in Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A in FinnGen and the UK Biobank.

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Managing thromboembolic risk in patients with hereditary and acquired thrombophilias.

Postdischarge thrombosis and hemorrhage in patients with COVID-19.

Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.

Should You Treat This Acutely Ill Medical Inpatient With Venous Thromboembolism Chemoprophylaxis?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.

A Balancing Act.

Issues in the Diagnosis and Management of Hereditary Antithrombin Deficiency.

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.

Heparin induced thrombocytopenia antibodies in Covid-19.

How Effective and Safe Is Factor XI Inhibition in Preventing Venous Thrombosis?

The challenge of hospital-related thrombosis.

The thrombogenicity of C1 esterase inhibitor (human): review of the evidence.

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).

Targeted Anti-Anticoagulants.

The dos, don'ts, and nuances of thrombophilia testing.

Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa.

Reversal of antithrombotic agents.